Scientific Publications

An Investment Case for the Accelerated Introduction of Oral Cholera Vaccines

2015-07-24 01:19
    IVI developed an investment case in order to provide a global evidence base for investing in oral cholera vaccines as part of a larger strategy that includes improvements to water, sanitation, and hygiene. This report was designed to meet the needs of groups that include the WHO Strategic Advisory Group of Experts on Immunization (SAGE), the international health community, vaccine manufacturers, prospective donor agencies, and policymakers from cholera-endemic countries for more information about the potential demand for cholera vaccines, the cost involved to meet this demand, and the impact and cost-effectiveness of vaccination.